The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7alpha(buta-1,3-dienyl)4-androsten-17alpha-ol-3-one ID: ALA4875435
PubChem CID: 164627404
Max Phase: Preclinical
Molecular Formula: C23H32O2
Molecular Weight: 340.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=C/C=C/[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@H](O)CC[C@H]3[C@H]12
Standard InChI: InChI=1S/C23H32O2/c1-4-5-6-15-13-16-14-17(24)9-11-22(16,2)19-10-12-23(3)18(21(15)19)7-8-20(23)25/h4-6,14-15,18-21,25H,1,7-13H2,2-3H3/b6-5+/t15-,18+,19+,20-,21+,22+,23+/m1/s1
Standard InChI Key: BZUCOOWOGJTBHA-HFLCBZEUSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
3.2499 -3.6916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2499 -4.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9619 -4.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9619 -3.2749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6739 -3.6916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6704 -4.5166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3792 -4.9298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0960 -4.5226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3862 -3.2799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0995 -3.7025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1166 -2.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3916 -2.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8299 -2.4698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8165 -3.2963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5984 -3.5646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0951 -2.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6201 -2.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5361 -4.9301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8081 -4.9392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5249 -4.5307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2370 -4.9472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9538 -4.5388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6666 -2.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8877 -1.4470 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3791 -4.1041 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.8082 -4.1207 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.0915 -2.8750 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.8249 -1.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 2 0
5 4 1 0
5 6 1 0
5 9 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 10 1 0
9 12 1 0
10 14 1 0
13 11 1 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
2 18 2 0
8 19 1 6
19 20 2 0
20 21 1 0
21 22 2 0
5 23 1 1
17 24 1 6
9 25 1 6
14 26 1 6
10 27 1 1
13 28 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.51Molecular Weight (Monoisotopic): 340.2402AlogP: 4.85#Rotatable Bonds: 2Polar Surface Area: 37.30Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.32CX LogD: 4.32Aromatic Rings: ┄Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: 2.65
References 1. Paquin A, Oufqir Y, Sevrioukova IF, Reyes-Moreno C, Bérubé G.. (2021) Innovative C2 -symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4., 220 [PMID:33933755 ] [10.1016/j.ejmech.2021.113496 ]